StockWatch
·
Surgical & Medical Instruments & Apparatus
LegalJul 29, 2026, 06:06 AM

PetVivo Terminates License Agreement with VetStem, Settles Disputes

AI Summary

PetVivo Holdings, Inc. announced it has entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24, 2026. This agreement formally terminates their Exclusive License and Supply Agreement and resolves all outstanding disputes and financial obligations between the parties. PetVivo's remaining financial commitment under the settlement is $75,000 in cash payments, and ownership of its PrecisePRP® Canine and Equine inventory has been transferred to VetStem. The company stated this allows them to focus on advancing their proprietary technologies and strategic growth initiatives.

Key Highlights

  • PetVivo terminated its Exclusive License and Supply Agreement with VetStem, Inc. effective July 24, 2026.
  • The termination resolves all disputes and outstanding financial obligations under the prior agreement.
  • PetVivo's sole remaining financial obligation is $75,000 in aggregate cash payments to VetStem.
  • Ownership of PetVivo's PrecisePRP® Canine and Equine inventory transferred to VetStem.
  • A warrant for 250,000 shares of PetVivo common stock held by VetStem remains in full force and effect.
  • The agreement allows PetVivo to focus resources on its proprietary product portfolio, including SPRYNG®.